Platycarya strobilacea leaf extract inhibits tumor necrosis factor-α production and bone loss induced by Porphyromonas gingivalis-derived lipopolysaccharide

Arch Oral Biol. 2018 Dec:96:46-51. doi: 10.1016/j.archoralbio.2018.08.011. Epub 2018 Aug 24.

Abstract

Objective: Remodeling of alveolar bone is controlled by osteoclast-mediated bone resorption and osteoblast-induced bone formation. LPS of Porphyromonas gingivalis, a major causative agent of periodontitis, produces proinflammatory cytokines in host immune cells, which thereby triggers osteoclastogenesis and leads to alveolar bone resorption. We investigated the anti-periodontitis potential of Platycarya strobilacea leaf extract (PLE), which is used as a traditional medicine in Asian countries.

Design: TNF-α levels in cell culture media were measured using a commercially available enzyme-linked immunosorbent assay kit. Osteoclast differentiation was observed by tartrate-resistant acid phosphatase staining, and the expression levels of osteoclastogenic genes were measured by quantitative real-time PCR. Bone-resorbing activity was confirmed by the resorption pit formation, gelatin zymographic, and the cathepsin K activity assays. Osteogenic differentiation was confirmed with an ALP activity assay and alizarin red S staining.

Results: PLE treatment inhibited the production of TNF-α in P. gingivalis LPS-stimulated RAW264.7 macrophages. In bone marrow-derived macrophages serving as osteoclast precursors, PLE treatment blocked RANKL-induced osteoclastogenesis and gene expression levels of the osteoclastogenic transcription factor NFATc1, DC-STAMP for osteoclast fusion, and cathepsin K for osteoclast activity. In addition, PLE treatment reduced the formation of resorption pits and the secretion of MMP 9 and cathepsin K from the differentiated osteoclasts. Furthermore, PLE treatment induced osteogenesis by increasing ALP activity and calcium content in preosteoblastic cells.

Conclusion: PLE inhibits P. gingivalis LPS-induced TNF-α production and bone resorption and induces bone formation. PLE may be a beneficial agent to promote oral health by inhibiting periodontitis-induced alveolar bone loss.

Keywords: Bone resorption; LPS; Osteogenic activity; Platycarya strobilacea extract; Porphyromonas gingivalis; TNF-α.

MeSH terms

  • Alveolar Bone Loss / microbiology
  • Alveolar Bone Loss / prevention & control*
  • Animals
  • Cell Differentiation / drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Juglandaceae / classification*
  • Lipopolysaccharides / pharmacology
  • Male
  • Mice
  • Osteoclasts / drug effects
  • Osteogenesis / drug effects
  • Plant Extracts / pharmacology*
  • Plant Leaves*
  • Porphyromonas gingivalis / metabolism*
  • Real-Time Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Lipopolysaccharides
  • Plant Extracts
  • Tumor Necrosis Factor-alpha